Wegovy maker Novo Nordisk is accusing Mr Huang and his firm of fraudulent claims over a hypertension drug. Read more at straitstimes.com.
Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...
U.S. President Donald Trump will meet on Thursday with chief executives from major drugmakers, a White House official ...
Danish pharmaceutical group Novo Nordisk is preparing to launch an ICC arbitration worth US$830 million against a Singapore ...
Healthcare costs and spending have been rising in the US. The Centers for Medicare & Medicaid Services reported that ...
President Donald Trump escalated trade tensions Tuesday by threatening to impose new 25% tariffs on automobiles, ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
While medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they ...
Between 2018 and 2024, China has launched 188 domestically developed innovative drugs – nearly double the number from the ...
US President Donald Trump has signalled plans to impose a 25% tariff on car imports, along with similar or higher levies on ...
A summary of current health news highlights a bird flu outbreak in Canada, halted HIV vaccine trials in South Africa, a legal ...
Novo Nordisk is seeking up to $830 million in damages from KBP Biosciences, according to a ruling by a Singapore court, as ...